2025 年 10 月,国家药监局发布的 2025 年 9 月医疗器械注册审批公告引发行业高度关注。当月共批准注册 348 个医疗器械产品,这一数字不仅延续了近年来我国医疗器械注册审批的高效节奏,更通过结构化数据勾勒出产业发展的鲜明轮廓。从产品来源看,境内第三类医疗器械以 276 个的绝对优势占据主导地位,占比达 79.3%;进口第三类、第二类医疗器械分别为 34 个和 36 个,合计占比 ...
Source Link2025 年 10 月,国家药监局发布的 2025 年 9 月医疗器械注册审批公告引发行业高度关注。当月共批准注册 348 个医疗器械产品,这一数字不仅延续了近年来我国医疗器械注册审批的高效节奏,更通过结构化数据勾勒出产业发展的鲜明轮廓。从产品来源看,境内第三类医疗器械以 276 个的绝对优势占据主导地位,占比达 79.3%;进口第三类、第二类医疗器械分别为 34 个和 36 个,合计占比 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.